SCHEMBL31097976

SCHEMBL31097976

O=C1CCCNc2ccccc2N1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.58
▸ NPC1 O15118 1/20 0.52
▸ MAPK13 O15264 1/20 0.52
▸ MAPK12 P53778 1/20 0.52
▸ MAPK11 Q15759 1/20 0.52
▸ MAPK14 Q16539 1/20 0.52
▸ OR51E2 Q9H255 1/20 0.48
▸ AHR P35869 1/20 0.44
▸ PDK2 Q15119 1/20 0.44
▸ BRD4 O60885 5/20 0.42
▸ CREBBP Q92793 5/20 0.42
▸ EP300 Q09472 1/20 0.42
▸ CRBN Q96SW2 2/20 0.41
▸ FKBP5 Q13451 1/20 0.41
▸ PLCG1 P19174 1/20 0.39
▸ GRIA1 P42261 1/20 0.38
▸ GRIA2 P42262 1/20 0.38
▸ GRIA3 P42263 1/20 0.38
▸ GRIA4 P48058 1/20 0.38
▸ MEN1 O00255 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4071447 0.88 NPC1 (0.55) MAPTNPC1MAPK13MAPK12MAPK11
Indoline SCHEMBL29002622 0.76 OR51E2 (0.54) MAPTNPC1MAPK13MAPK12MAPK11
SCHEMBL13444608 0.75 GAA (0.44) MAPTNPC1MEN1KMT2AALDH1A1
SCHEMBL4495411 0.75 GAA (0.44) MAPTNPC1MEN1KMT2AALDH1A1
SCHEMBL293197 0.75 GAA (0.44) MAPTNPC1MEN1KMT2AALDH1A1
SCHEMBL12387707 0.74 MAPT (0.43) MAPTNPC1MAPK13MAPK12MAPK11
SCHEMBL27511029 0.74 MAPT (0.56) MAPTNPC1MAPK13MAPK12MAPK11
SCHEMBL29483964 0.74 AHR (0.50) MAPTNPC1MAPK13MAPK12MAPK11
SCHEMBL37900 0.74 AHR (0.50) MAPTNPC1MAPK13MAPK12MAPK11
SCHEMBL2138422 0.73 MAPT (0.92) MAPTNPC1MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118632841-A Heterocyclic compounds for the treatment of cancer 阿提奥斯医药有限公司 2024-09-10 — — CN disclosed
Send feedback